ArticleBreast care (Basel, Switzerland)2022

Treatment Strategy for Patients with HR-Positive HER2-Negative Metastatic Breast Cancer That Progressed on CDK4/6 Inhibitors.

Shouko Hayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.